Stockscreener 앱 받기
90.66
1.66%
-1.53
시장 영업 전:
91.29
0.63
+0.69%
전일 마감가:
$92.19
열려 있는:
$92.12
하루 거래량:
162.13K
Relative Volume:
1.57
시가총액:
$1.16B
수익:
$86.28M
순이익/손실:
$23.61M
주가수익비율:
49.38
EPS:
1.8359
순현금흐름:
$23.97M
1주 성능:
-1.56%
1개월 성능:
+8.30%
6개월 성능:
-2.75%
1년 성능:
+55.93%
1일 변동 폭
$90.54
$94.45
1주일 범위
$89.17
$94.62
52주 변동 폭
$55.11
$107.90
Iradimed Corp Stock (IRMD) Company Profile
명칭
Iradimed Corp
전화
(407) 677-8022
주소
12705 INGENUITY DRIVE, ORLANDO
Compare IRMD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
90.66 | 1.18B | 86.28M | 23.61M | 23.97M | 1.8359 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-04-12 | 개시 | Lake Street | Buy |
| 2017-10-31 | 재개 | ROTH Capital | Buy |
| 2016-10-05 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2015-11-02 | 재확인 | ROTH Capital | Buy |
| 2015-07-30 | 재확인 | ROTH Capital | Buy |
| 2015-06-16 | 재확인 | ROTH Capital | Buy |
| 2015-01-12 | 재확인 | ROTH Capital | Buy |
| 2014-12-23 | 재확인 | ROTH Capital | Buy |
모두보기
Iradimed Corp 주식(IRMD)의 최신 뉴스
Iradimed Corp Quarterly Report Highlights Key Growth DriversEarnings Call Q&A - thelegaladvocate.com
Iradimed Reports 13 Percent Revenue Growth in First Quarter of 2026 - HarianBasis.co
IRADIMED (IRMD) CEO-linked trust sells 7,500 shares in 10b5-1 plan - Stock Titan
Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report - Insider Monkey
IRMD Stock Chart | IRADIMED CORP (NASDAQ:IRMD) - ChartMill
Iradimed’s CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors? - sharewise.com
IRadimed’s Earnings Call Highlights 3870-Led Growth - TipRanks
iRadimed Corp (IRMD) Rallies 3% as Medical Device Stock Holds Key SupportOpen Market Insights - Newser
Iradimed CEO Roger Susi sells $657,264 in company stock By Investing.com - Investing.com Australia
Iradimed CEO Roger Susi sells $657,264 in company stock - Investing.com
CEO’s trust sells 7,500 IRADIMED (IRMD) shares under Rule 10b5-1 plan - Stock Titan
IRADIMED CEO and CFO head to Goldman Sachs health conference in Miami - Stock Titan
iRadimed Corporation (IRMD) Crushes Q1 2026 Estimates — EPS $0.49 Tops ViewsEarnings Revision Downgrade - thelegaladvocate.com
Iradimed (NASDAQ: IRMD) family trusts disclose 4.45M shares, 34.8% ownership - Stock Titan
IRADIMED (IRMD) CEO Susi’s trust sells 7,500 pre-planned shares - Stock Titan
Reaffirmed Outlook And Dividend: What Does IRMD’s Confidence Signal About Its MRI Pump Moat? - Yahoo Finance
The Bull Case For IRADIMED (IRMD) Could Change Following Q1 Results And Reaffirmed 2026 GuidanceLearn Why - Sahm
TradingKey - TradingKey
Here's What We Like About IRADIMED's (NASDAQ:IRMD) Upcoming Dividend - Yahoo Finance
IRMD (iRadimed Corporation) beats Q1 estimates with 14.4% revenue growth, but shares dip despite strong results.Attention Driven Stocks - Newser
A Look At IRADIMED (IRMD) Valuation As Long Term Returns Contrast With Recent Share Price Weakness - Yahoo Finance
Iradimed CEO Roger Susi sells $642,861 in company stock By Investing.com - Investing.com South Africa
Iradimed CEO Roger Susi sells $642,861 in company stock - Investing.com
IRADIMED (IRMD) CEO-linked trust sells 7,500 shares under 10b5-1 plan - Stock Titan
Is IRADIMED’s 3870 Pump Launch And Reaffirmed Outlook Altering The Investment Case For IRMD? - Sahm
IRadimed Corporation (NASDAQ:IRMD) Q1 2026 Earnings Call Transcript - Insider Monkey
IRadimed Rides 3870 Momentum Despite Near-Term Dip - TipRanks
IRMD (iRadimed Corporation) tops Q1 2026 EPS estimates by 8 percent, shares rise 4.45 percent in today’s session.Revenue Inflection Point - thelegaladvocate.com
iRadimed (NASDAQ:IRMD) Issues Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
IRadimed Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
iRadimed Corporation (NASDAQ:IRMD) Given Consensus Rating of "Buy" by Analysts - MarketBeat
IRADIMED CORPORATION Files Form 8-K with SEC for May 2026 – Company Information, Address, and Stock Exchange Details - Minichart
iRadimed Corp (IRMD) Q1 2026 Earnings Call Highlights: Strong Re - GuruFocus
Why Iradimed Stock Topped the Market Today - Yahoo Finance
iRadimed Corp (IRMD) Shares Surge 4.4% -- What GF Score of 95 Te - GuruFocus
iRadimed Corporation (NASDAQ:IRMD) Plans Quarterly Dividend of $0.20 - MarketBeat
IRADIMED CORP 1Q 2026: Revenue $21.98M, EPS $0.45— 10-Q Summary - TradingView
IRADIMED (NASDAQ: IRMD) Q1 2026 revenue rises 13% to $22M - Stock Titan
iRadimed (NASDAQ:IRMD) Sees Large Volume IncreaseShould You Buy? - MarketBeat
iRadimed Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: Iradimed Co beats Q1 2026 expectations, stock dips - Investing.com
iRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
IRadimed Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Iradimed reports Q1 2026 revenue $22.0M, GAAP EPS $0.45; declares $0.20 quarterly dividend - TradingView
iRadimed (NASDAQ:IRMD) Updates FY 2026 Earnings Guidance - MarketBeat
iRadimed (NASDAQ:IRMD) Issues Q2 2026 Earnings Guidance - MarketBeat
IRADIMED ($IRMD) Releases Q1 2026 Earnings - Quiver Quantitative
IRADIMED (NASDAQ: IRMD) Q1 growth, dividend and 2026 outlook - Stock Titan
IRadimed: Q1 Earnings Snapshot - WKYC
MRI device maker IRADIMED launches new pump as Q1 sales climb 13% - Stock Titan
Roger Susi Sells 3,750 Shares of iRadimed (NASDAQ:IRMD) Stock - MarketBeat
Iradimed Corp (IRMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.59%
1.94%
자본화:
|
볼륨(24시간):